45% of Gen Z women and 35% of millennials now use social media for health information, a stark contrast to just 6% of baby boomers, according to eMarketer. The generational divergence reveals a profound shift in how individuals, particularly younger demographics, seek and consume health-related content. The digital realm has become a primary resource, influencing health choices and perceptions on an unprecedented scale.

Younger generations are increasingly seeking health information on social media and digital platforms, but pharmaceutical advertisers are still significantly increasing their spend on national TV drug advertising. This creates a measurable disconnect between where marketing dollars are allocated and where the future patient base is actively engaging with health topics.

Companies that fail to pivot their health communication and marketing strategies towards digital and AI-driven channels risk becoming irrelevant to a growing segment of the health-conscious consumer base. Adapting to these evolving behaviors is critical for long-term market relevance and patient engagement.

The New Gatekeepers of Health Information

In 2026, search engines, social media platforms, and connected TV (CTV) have become the most influential touchpoints for consumers seeking health answers and discovery, reports eMarketer. This digital dominance means that traditional information sources are losing their grip on consumer attention and influence, particularly among younger audiences. The shift fundamentally redefines of how individuals access health education and become aware of pharmaceutical products.

Consumers now expect immediate, accessible, and often personalized health insights, a demand primarily met by digital channels. Platforms offering user-generated content, expert opinions, and community forums provide a multi-faceted approach to health discovery that linear television cannot replicate. This evolving ecosystem requires pharmaceutical companies to engage directly within these influential digital spaces.

Billions Still Flow to Traditional Airwaves

  • $5.96 billion — Pharma advertisers spent this amount on national TV drug advertising in 2025, an increase of 16% year-over-year, according to eMarketer.